Regulatory Correspondence
0.1.0 - ci-build
Regulatory Correspondence, published by Gravitate Health and HL7 Vulcan. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cander2/rfi-ig/ and changes regularly. See the Directory of published versions
{
"resourceType": "Bundle",
"id": "rfi-bundle-003",
"url": "http://hl7.org/fhir/uv/rfi-ig/Bundle/response-bundle-003",
"type": "collection",
"entry": [
{
"resource": {
"resourceType": "Communication",
"id": "rfi-comm-003",
"status": "in-progress",
"category": [
{
"coding": [
{
"system": "http://hl7.org/fhir/rfi-type",
"code": "RFI"
}
]
}
],
"sender": {
"reference": "Organization/FDA"
},
"recipient": {
"reference": "Organization/MAH-PharmaCorp"
},
"basedOn": [
{
"reference": "MedicinalProductDefinition/NDA78901"
}
],
"payload": [
{
"contentReference": {
"reference": "Questionnaire/rfi-question-003"
}
}
],
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/rfi-due-date",
"valueDateTime": "2025-07-15T23:59:59Z"
}
]
}
},
{
"resource": {
"resourceType": "Questionnaire",
"id": "rfi-question-003",
"status": "active",
"item": [
{
"linkId": "q1",
"type": "group",
"text": "Provide details on the drug product packaging.",
"code": [
{
"system": "http://hl7.org/fhir/rfi-category",
"code": "CMC"
},
{
"system": "http://hl7.org/fhir/rfi-subcategory",
"code": "DrugProduct"
}
],
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/rfi-question-id",
"valueString": "Q003"
}
],
"item": [
{
"linkId": "q1.1",
"type": "display",
"text": "**Packaging Details**: Describe the primary packaging materials and their compatibility with the drug product."
},
{
"linkId": "q1.2",
"type": "attachment",
"text": "Upload an image of the packaging."
},
{
"linkId": "q1.3",
"type": "display",
"text": "Provide any additional notes on packaging stability or testing."
}
]
}
]
}
}
]
}
{
"resourceType": "Bundle",
"id": "response-bundle-003",
"url": "http://hl7.org/fhir/uv/rfi-ig/Bundle/rfi-bundle-003",
"type": "collection",
"entry": [
{
"resource": {
"resourceType": "QuestionnaireResponse",
"id": "rfi-response-003",
"questionnaire": "Questionnaire/rfi-question-003",
"status": "completed",
"author": {
"reference": "Practitioner/PackagingLead"
},
"source": {
"reference": "Communication/rfi-comm-003"
},
"item": [
{
"linkId": "q1",
"item": [
{
"linkId": "q1.1",
"answer": [
{
"valueString": "The primary packaging uses high-density polyethylene (HDPE) bottles, which are compatible with the drug product. Compatibility tests confirm no leaching or degradation."
}
]
},
{
"linkId": "q1.2",
"answer": [
{
"valueAttachment": {
"contentType": "image/jpeg",
"data": "iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNkYAAAAAYAAjCB0C8AAAAASUVORK5CYII=",
"title": "HDPE Bottle Image"
}
}
]
},
{
"linkId": "q1.3",
"answer": [
{
"valueString": "Stability tests under 25°C/60%RH show no packaging-related issues over 24 months. Additional stress testing data is available upon request."
}
]
}
]
}
]
}
}
]
}